Athira Pharma, Inc.
ATHA
$0.36
$0.01885.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.37% | 17.62% | 9.38% | -5.30% | -13.38% |
| Total Depreciation and Amortization | -0.41% | 0.10% | 0.93% | 2.42% | 5.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.79% | 14.42% | 11.00% | 1.49% | -5.77% |
| Change in Net Operating Assets | -415.39% | -283.58% | -98.59% | -53.97% | -42.53% |
| Cash from Operations | 14.28% | 3.56% | -8.13% | -12.11% | -22.26% |
| Capital Expenditure | 58.82% | 89.14% | 89.18% | 87.86% | 89.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.58% | -42.49% | -43.63% | -37.51% | 3.86% |
| Cash from Investing | -52.57% | -42.34% | -43.51% | -37.26% | 4.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -50.76% | -60.65% | -36.07% | -38.52% | -27.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -50.76% | -60.65% | -36.07% | -38.52% | -27.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -87.85% | -715.05% | -239.65% | -265.47% | -124.12% |